ARTICLE | Clinical News
Fareston toremifene citrate regulatory update
February 2, 2009 8:00 AM UTC
EMEA's CHMP recommended that Orion's Fareston toremifene should not be used in patients at risk of prolonged QT intervals or other heart problems. The non-steroidal selective estrogen receptor modulat...